165 related articles for article (PubMed ID: 29533008)
1. Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.
Orbach D; Mosseri V; Pissaloux D; Pierron G; Brennan B; Ferrari A; Chibon F; Bisogno G; De Salvo GL; Chakiba C; Corradini N; Minard-Colin V; Kelsey A; Ranchère-Vince D
Cancer Med; 2018 Apr; 7(4):1384-1393. PubMed ID: 29533008
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Lagarde P; Przybyl J; Brulard C; Pérot G; Pierron G; Delattre O; Sciot R; Wozniak A; Schöffski P; Terrier P; Neuville A; Coindre JM; Italiano A; Orbach D; Debiec-Rychter M; Chibon F
J Clin Oncol; 2013 Feb; 31(5):608-15. PubMed ID: 23319690
[TBL] [Abstract][Full Text] [Related]
3. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.
Przybyl J; Sciot R; Wozniak A; Schöffski P; Vanspauwen V; Samson I; Siedlecki JA; Rutkowski P; Debiec-Rychter M
Int J Biochem Cell Biol; 2014 Aug; 53():505-13. PubMed ID: 24842110
[TBL] [Abstract][Full Text] [Related]
5. Synovial sarcoma. A Scandinavian Sarcoma Group project.
Skytting B
Acta Orthop Scand Suppl; 2000 Apr; 291():1-28. PubMed ID: 10862210
[TBL] [Abstract][Full Text] [Related]
6. [Synovial sarcoma in children and adolescents].
Mansuy L; Bernier V; Ranchère-Vince D; Mainard L; Orbach D; Corradini N
Bull Cancer; 2016 Feb; 103(2):210-8. PubMed ID: 26774699
[TBL] [Abstract][Full Text] [Related]
7. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
Ferrari A; De Salvo GL; Brennan B; van Noesel MM; De Paoli A; Casanova M; Francotte N; Kelsey A; Alaggio R; Oberlin O; Carli M; Ben-Arush M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Orbach D
Ann Oncol; 2015 Mar; 26(3):567-72. PubMed ID: 25488687
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
Stegmaier S; Leuschner I; Poremba C; Ladenstein R; Kazanowska B; Ljungman G; Scheer M; Blank B; Bielack S; Klingebiel T; Koscielniak E
Pediatr Blood Cancer; 2017 Jan; 64(1):89-95. PubMed ID: 27621063
[TBL] [Abstract][Full Text] [Related]
9. Response to chemotherapy is not related to chromosome instability in synovial sarcoma.
Chakiba C; Lagarde P; Pissaloux D; Neuville A; Brulard C; Pérot G; Coindre JM; Terrier P; Ranchere-Vince D; Ferrari A; Collini P; Suurmeijer AJH; Blay JY; Terrisse SA; Piperno-Neumann S; Averous G; Bui B; Orbach D; Italiano A; Chibon F
Ann Oncol; 2014 Nov; 25(11):2267-2271. PubMed ID: 25070544
[TBL] [Abstract][Full Text] [Related]
10. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
11. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.
Brecht IB; Ferrari A; Int-Veen C; Schuck A; Mattke AC; Casanova M; Bisogno G; Carli M; Koscielniak E; Treuner J
Pediatr Blood Cancer; 2006 Jan; 46(1):11-7. PubMed ID: 16292743
[TBL] [Abstract][Full Text] [Related]
12. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
13. Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma.
Balogh Z; Szemlaky Z; Szendroi M; Antal I; Pápai Z; Fónyad L; Papp G; Changchien YC; Sápi Z
Diagn Pathol; 2011 Nov; 6():107. PubMed ID: 22053830
[TBL] [Abstract][Full Text] [Related]
14. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
[TBL] [Abstract][Full Text] [Related]
15. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract][Full Text] [Related]
16. Synovial sarcoma: identification of low and high risk groups.
Bergh P; Meis-Kindblom JM; Gherlinzoni F; Berlin O; Bacchini P; Bertoni F; Gunterberg B; Kindblom LG
Cancer; 1999 Jun; 85(12):2596-607. PubMed ID: 10375108
[TBL] [Abstract][Full Text] [Related]
17. Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.
Ferrari A; Chi YY; De Salvo GL; Orbach D; Brennan B; Randall RL; McCarville MB; Black JO; Alaggio R; Hawkins DS; Bisogno G; Spunt SL
Eur J Cancer; 2017 Jun; 78():1-6. PubMed ID: 28391003
[TBL] [Abstract][Full Text] [Related]
18. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
19. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
[TBL] [Abstract][Full Text] [Related]
20. Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.
Stanelle EJ; Christison-Lagay ER; Healey JH; Singer S; Meyers PA; La Quaglia MP
Ann Surg Oncol; 2013 Jan; 20(1):73-9. PubMed ID: 22878620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
